Clinical trial
Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)
NCT00257959 · Connolly, Stuart, M.D., Other · Completed
Key facts
| NCT number | NCT00257959 |
|---|---|
| Title | Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) |
| Lead sponsor | Connolly, Stuart, M.D., Other |
| Collaborators | Abbott Medical Devices Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ventricular Tachycardia |
| Intervention type | Drug |
| Interventions | amiodarone beta blocker sotalol |
| Enrollment | 400 |
| Start date | Jan 1, 2001 |
| Completion | Oct 1, 2004 |
| First posted | Nov 24, 2005 |
| Last update posted | Jul 27, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: